EW

Edwards Lifesciences Corporation

Healthcare
86.60 -1.50 -1.70% Pre-Market
2026-10-16 • USD

Key Metrics

Market Cap 49.92B
EV 46.37B
Shares Out 576.40M
Revenue (ttm) 6.51B
Net Income 1.00B
Beta —
P/E —
Forward P/E —
EPS (ttm) $1.74
P/S 7.66
P/B 4.70
P/FCF 34.82
P/C 29.02
EV/Sales 7.12
EV/EBITDA 28.80
ROA 7.41%
ROE 9.65%
ROIC 8.83%
Gross Margin 77.84%
Oper. Margin 22.25%
Profit Margin 15.43%
Debt/Eq 0.07
LT Debt/Cap 5.34%
Quick Ratio 3.33
Current Ratio 4.52
Book/sh 18.42
Cash/sh 5.04
Div Yield —
Div TTM —
Payout Ratio —
SMA20 0.16%
SMA50 -2.06%
SMA200 1.72%
Volume 4,007,412
Avg Volume 4.06M
Rel Volume 0.99
Perf Week 0.24%
Perf Month -1.88%
Perf Quarter 1.01%
Perf Half Y 6.93%
Perf YTD 1.58%
Perf Year 16.02%
Perf 3Y 25.36%
Perf 5Y -24.70%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Edwards Lifesciences Corporation is the leading global structural heart innovation company driven by a passion to improve patient lives. Through breakthrough technologies,…

Name
Edwards Lifesciences Corporation
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Bernard Zovighian · Chief Executive Officer
Employees
16,000 as of 2025-12-31
IPO Date
2018-12-18
Phone
(949) 250-2500
Address
One Edwards Way, Irvine, CA 92614
Website
www.edwards.com

Key Executives

Name Title FY Pay
Bernard Zovighian Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.